![ADA: Real-world data show lower A1c levels with Abbott's FreeStyle Libre CGM in Type 2 diabetes | Fierce Biotech ADA: Real-world data show lower A1c levels with Abbott's FreeStyle Libre CGM in Type 2 diabetes | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1560170841/FreeStyle%20Libre%20US.png/FreeStyle%20Libre%20US.png?VersionId=etqBrMRc7jj7EnKz4Vzzn6zpfcVvtl0D)
ADA: Real-world data show lower A1c levels with Abbott's FreeStyle Libre CGM in Type 2 diabetes | Fierce Biotech
![Abbott's FreeStyle Libre: A new painless way to manage time in range for diabetes patients | Technology News,The Indian Express Abbott's FreeStyle Libre: A new painless way to manage time in range for diabetes patients | Technology News,The Indian Express](https://images.indianexpress.com/2020/11/abbott-freestyle-libre.jpg)
Abbott's FreeStyle Libre: A new painless way to manage time in range for diabetes patients | Technology News,The Indian Express
![Study Finds Freestyle Libre Reduces Acute Complication in Type-2 Diabetes Insulin Treatment | The Healthcare Technology Report. Study Finds Freestyle Libre Reduces Acute Complication in Type-2 Diabetes Insulin Treatment | The Healthcare Technology Report.](https://thehealthcaretechnologyreport.com/wp-content/uploads/2022/10/Freestyle-Libre.jpeg)
Study Finds Freestyle Libre Reduces Acute Complication in Type-2 Diabetes Insulin Treatment | The Healthcare Technology Report.
![Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021 Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021](https://mma.prnewswire.com/media/1585773/Abbott_FreeStyle_Libre_2.jpg?p=original)